We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Device Books » Design Change Analysis: Five Steps to Compliance

Other Options

PDF Edition

$397.00

PDF Edition - 3-4 Copies (10% Off)

$357.00

PDF Edition - 5-6 Copies (15% Off)

$337.00

PDF Edition - 7-9 Copies (20% Off)

$317.00

PDF Edition - 10+ Copies (25% Off)

$297.00
Design Change Analysis

Design Change Analysis: Five Steps to Compliance

$397.00
Device Books

Product Details

Medical device design change is a demanding and uneasy process. Failure to dot all your i’s and cross all your t’s can lead to inspection problems and missed market opportunities.

FDA QSR §820.30(i) spells out the basics of design change but is only the starting place for you and your team.

In Design Change Analysis: Five Steps to Compliance — Dan O’Leary — an industry expert with more than 30 years of experience in quality, operations and program management — presents a comprehensive plan for creating a robust design change procedure, including discussion of the primary FDA regulations and ISO standards governing design change, as well as flowcharts and decision-making tools to walk you through the five steps to compliance:

  1. How production and process changes impact design change
  2. When a design change requires a new device identifier to be assigned
  3. Whether the change requires submission of a new 510(k)
  4. Whether the change will require a correction or removal of devices from the field
  5. Whether changes need to be made to the device’s risk management file

Keep all the moving parts of design change in sync with Design Change Analysis, which lays out the factors you must consider along with the decisions you must make.

About the Contributor

Dan O’Leary is president of Ombu Enterprises LLC, a company offering training and execution in operational excellence focusing on analytic skills and a systems approach to operations management. Mr. O’Leary has 30+ years’ experience in quality, operations, and program management in regulated industries including medical devices and clinical labs. He is an ASQ certified Biomedical Auditor, Quality Auditor, Quality Engineer, Reliability Engineer, and Six Sigma Black Belt; and is certified by APICS in Resource Management.

Who Will Benefit

  • Design Engineers
  • Manufacturing Engineers
  • Quality Engineers
  • Risk Managers
  • Regulatory Affairs Professionals

PDF

$397.00
Add to Cart

Contributor:
Dan O’Leary

ISBN-13:
978-1-60430-117-5

Publication date:
January 2020

Page count:
366


Multi-user Access
Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Books Library — a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.


Our Guarantee
Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing